E

Active Director Director DIN 11115324
DIN 11115324 First appointment May 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since May 2025
Shareholding value Locked Premium profile

About Eshmita

Eshmita has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Jmed Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11115324
Primary Designation Director
First Appointment 20 May 2025
Oldest Company Age 3 yrs

Current companies

Company Designation Appointment Founded Status
Jmed Pharmaceuticals Private Limited U24290JH2023PTC019862
Director 20 May 2025 2023 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Eshmita

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Eshmita

Eshmita has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Jmed Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Eshmita is associated with 1 company as Director.

Eshmita has expertise in General Business.

Eshmita has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available